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Abstract 
Introduction and objectives. To determine the prevalence and geographic distribution of major cardiovascular risk 
factors in the Spanish population. To investigate whether geographic variability exists. 
Methods. Data were pooled from eight cross-sectional epidemiologic studies carried out in Spain between 1992 and 
2001 whose methodological quality satisfied predefined criteria. Individual data were reassessed and analyzed by age 
group (20-44 years, 45-64 years, and [.greaterequal] 65 years), sex, and geographic area. The study population 
included 19 729 individuals. Mean values and unadjusted and adjusted prevalence rates were derived for various risk 
factors. 
Results. The most common cardiovascular risk factors in the Spanish population were, in descending order: 
hypercholesterolemia (ie, total cholesterol >200 mg/dL) in46.7%, hypertension in 37.6%, smoking in 32.2%, obesity 
in 22.8%, and diabetes mellitus in 6.2%. The mean values for blood pressure, body mass index, high-density 
lipoprotein cholesterol, and glycemia varied considerably with age, sex, and geographic area. The highest levels of 
cardiovascular risk factors were observed in Mediterranean and south-eastern areas of the country and the lowest, in 
northern, and central areas. 
Conclusions. The prevalence of major cardiovascular risk factors in Spain was high. Their distribution varied 
considerably with geographic area. 
Resumen 
Introducción y objetivos. Estimar la prevalencia y la distribución geográfica de los principales factores de riesgo 
cardiovascular en la población española. Investigar la existencia de diferencias geográficas. 
Métodos. Agregación de ocho estudios epidemiológicos transversales, realizados en España entre 1992 y 2001, que 
superaron criterios de calidad metodológica. Reanálisis conjunto de los datos individuales por grupos de edad (20-44, 
45-64 y [.greaterequal] 65 años), sexo y grandes áreas geográficas. Población de estudio: 19.729 sujetos. Estimación 
de valores medios y prevalencias crudas y ajustadas. 
Resultados. Por orden decreciente, los factores de riesgo cardiovascular más frecuentes en la población española 
fueron la hipercolesterolemia (colesterol total > 200 mg/dl, 46,7%), hipertensión arterial (37,6%), tabaquismo 
(32,2%), obesidad (22,8%) y diabetes mellitus (6,2%). Los valores medios de presión arterial, índice de masa 
corporal, colesterol de las lipoproteínas de alta densidad y glucemia varían ampliamente con la edad, el sexo y las 
áreas geográficas. La mayor carga de factores de riesgo cardiovascular se observa en las zonas sureste y mediterránea 
y la menor, en las áreas norte y centro. 
Conclusiones. En España la prevalencia de los principales factores de riesgo cardiovascular es elevada. Hay marcadas 
diferencias geográficas en su distribución. 
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Palabras clave Epidemiología; Factores de riesgo cardiovascular; Diferencias regionales; España 
Abbreviations BMI, body mass index; BP, blood pressure; CVRF, cardiovascular risk factor; DM, diabetes mellitus; 
HCT, hypercholesterolemia; HT, hypertension; TC, total cholesterol concentration 
  
Introduction 
Ischemic heart disease accounts for 32% of all cardiovascular deaths in Spain. This percentage is higher 
among men (40%) than among women (24%).1 
Knowledge of the main modifiable cardiovascular risk factors (CVRFs) in ischemic heart disease 
allows cardiovascular prevention strategies to be drawn up and implemented. The classic modifiable 
CVRFs are smoking, hypertension, hypercholesterolemia, and diabetes mellitus (DM). Different authors 
have indicated that coronary artery disease can occur in up to 50% of cases in the absence of these 
CVRFs,2,3 but recent studies show that the classic CVRFs are determinant.4-7 Therefore, studies of 
prevalence of CVRFs are still justified to generate hypotheses and define health policies for 
cardiovascular prevention.  
In Spain, several epidemiologic studies have been performed on CVRFs. A recent metaanalysis8 
identified 47 cross-sectional studies in Spain published between 1990 and 2003, with a total of 130 945 
patients. Although cross-sectional studies are available for different geographic areas of Spain, to date, no 
pooling of individual data on the participants had been performed for these studies.  
The objective of this study was to estimate the distribution of body mass index (BMI), blood pressure 
(BP), fasting blood glucose, total cholesterol concentration (TC), and high-density lipoprotein cholesterol 
(HDL-C) concentration, and to estimate the prevalence of hypertension, hypercholesterolemia, DM, 
smoking, and obesity by age-sex groups and geographic area. To do this, data from different cross-
sectional studies with similar methodology conducted between 1992 and 2001 were pooled and analyzed.  
Methods  
Data Sources  
A joint database was created with the individual data from all subjects participating in 8 cross-sectional 
epidemiologic studies performed by participating nodes of the ERICE network (Appendix, Table 1).9-16 
Table 1. Characteristics of the Original Studies Included in the ERICE Study 




   Men Women Total  
       
EPICARDIAN9 
Madrid, Lugo, Arévalo (R/U) 3 
districts; 1994 
Random, stratified by age and 
sex 
1628 2121 3749 >65 
VIVA10 
Arévalo, Talavera, Guadalajara, 
Lugo, Avilés, Vic, Alicante, Mérida, 
Pizarra (R/U), 9 municipalities; 1996 
Random, stratified by age, sex, 
and municipality 
1341 1602 2943 35-64 
HORA11 Spain (R/U), national; 2001 
Random sample, multiple age 
groups, pooled 
1452 2564 4016 >60 
REGICOR12 Gerona (R), district; 1997 
Two age groups, stratified by 
size of population, age, sex 
838 910 1748 25-74 
CORSAIB16 Majorca (R/U), provincial; 1999 Random multiple age groups  814 871 1685 35-74 
Talavera14 Talavera (R/U), district; 1995 
Random multiple age groups 
stratified by size of 
municipalities, age, and sex 
630 703 1333 25-74 
GEVA13 Albacete (R/U), provincial; 1996 Two age groups with pooling  612 710 1322 >18 
Murcia15 Murcia (R/U), regional; 1992 
Random, stratified by sex, age, 
type of residence, and health 
area, and pooled by municipality 
1514 1577 3091 18-65 
       
 
Environment indicates national, regional, provincial, district, municipal; R, rural environment; R/U, rural and urban environment. 
  
The studies included met the following criteria: 
 
– Single or multicenter studies done in Spain between 1992 and 2001, which included a general adult 
population of both sexes aged over 20 years, with more than 1 age group 
– Selection of the participants by random sampling, with a description of the target population, the 
sampling method, rate of participation, and an acceptable description of the statistical methods used 
(prespecified sample size, statistical power of the study, and level of precision of the estimates) 
– Use of standardized and validated measurement methods for the primary outcome measures of the study 
(BP, lipid profile, weight, height, smoking, blood glucose) 
– All the studies, except the HORA study, took a fasting blood sample (at least 10 hours without food) 
with measurement of the lipid fractions (TC, HDL-C), and blood glucose levels  
Variables Studied and Definition  of Cardiovascular Risk Factors 
The final joint database included the following study variables: study characteristics (date of data 
collection, sampling method, and rate of participation), sociodemographic data (age, sex, and place of 
residence), anthropometric variables (weight and height), BP and heart rate, cigarette consumption, 
laboratory data (TC, HDL-C, and fasting blood glucose), and personal history of stroke, ischemic heart 
disease, hypertension, hypercholesterolemia, diabetes, and pharmacologic treatment of these conditions.  
Hypertension was classed as systolic BP  ≥ 140 mm Hg or diastolic BP  ≥ 90 mm Hg, or treatment 
with antihypertensive agents. 17 DM was defined when venous blood glucose levels in fasting conditions 
were greater than 126 mg/dL or the subject was being treated with oral antidiabetic agents or insulin.18 
Two criteria for hypercholesterolemia were considered: TC concentration ≥ 200 mg/dL or treatment with 
lipid-lowering agents and TC  ≥ 250 mg/dL or treatment with lipid-lowering agents.19 Body mass index 
(BMI) was calculated for each individual using the formula of weight in kilograms divided by the square 
of height in meters, and obese patients were considered those with a BMI  ≥ 30. 20 A regular smoker was 
considered to be one who smoked 1 cigarette per day or 5 per week in the last year, an occasional smoker 
was one who smoked 4 cigarettes or less per week, and an ex-smoker was someone who had not smoked 
a cigarette in the last year. 21 
Data Analysis   
Before entering the data, an analysis of homogeneity among the different studies was undertaken. This 
was done by checking the heterogeneity by age and sex of the variances of the main variables, using the 
Levene test for equality of variances or the analysis of variance (ANOVA) according to whether 2 or 
more studies contributed to the estimation of the given variable. Homogeneity was not accepted for 
variables with P <.05, and data with significant heterogeneity were discarded.   
To guarantee sufficient statistical power for the estimators by geographic area, 4 large areas were 
defined that grouped together different autonomous regions: North (Galicia, Asturias, Aragon, Basque 
Country, Navarre, La Rioja), Mediterranean (Balearics, Catalonia, Valencia), Center (Castile-La Mancha, 
Castile-León, Madrid, Extremadura), and South-East (Andalusia and Murcia). Age and sex groups with 
fewer than 30 individuals represented in a given geographic area were discarded.   
For description of the selected data, basic statistics for central tendency were used—arithmetic mean 
with standard deviation (SD) when the variables were considered continuous and relative frequency 
distribution (prevalence) and their 95% confidence intervals (CI) when these variables were considered 
categoric, by age groups (20-44 years, 45-64 years, and  ≥ 65 years), and sex.   
For comparison of measures, the Student-Fisher t test was used in the case of independent binary 
measures and analysis of variance for variables of more than 2 categories. To quantify the size of the 
difference in prevalences of the CVRFs among geographic areas, the ratio of prevalences was used, 
taking as reference the lowest value for each factor. 
For comparison among geographic areas, the prevalence of the different CVRF, the rates were 
adjusted using the direct method, using the general Spanish population in 2006 as the standard 
population. 22  
  
Results   
Sociodemographic Characteristics of the Study Population   
The analysis of homogeneity between studies did not show significant differences between the different 
variables in most of the age and sex groups, and so the data could be pooled without affecting the internal 
validity. Heterogeneity was only observed in some of the least well represented age and sex groups: for 
BMI in those under 45 years old ( P =.01), for diastolic BP in those aged over 65 years ( P =.038), and for 
TC in women under 45 years old ( P =.04).   
The final sample for analysis comprised 19 729 subjects with full information for all the 
aforementioned variables. Table 2 shows the distribution by age, sex, and large geographic areas of the 
sample analyzed. The mean (SD) age was 57.6 (17.02) years, and 55.5% of participants were women and 
42.5% were over 65 years of age. Differences were observed in the distribution by age and sex between 
geographic areas ( P =.01).  
Table 2. Distribution of the Study Population by Age, Sex, and Geographic Area 
 Age Group, y  Total 
 20-44  45-64  ≥ 65   
 % No.  % No.  % No.  % No. 
 
Population 
Men 12.5 2465  14.1 2782  17.9 3528  44.5 8779 
Women 13.6 2683  17.3 3412  24.6 4855  55.5 10 950 
Total 26.1 5148  31.4 6194  42.5 8383  100 19 729 
North 7.4 179  22.8 554  69.8 1698  12.3 2431 
Mediterranean 26.3 1383  42.9 2259  30.8 1618  26.7 5260 
Center 18.3 1403  25.5 1956  56.2 4319  38.9 7678 
South-east 50.2 2187  32.7 1425  17.2 648  22.1 4360 
            
 
Distribution of Mean BMI, Systolic BP, Diastolic BP, Blood Glucose, TC, and HDL-C by Age, Sex, and 
Geographic Area   
The mean of all CVRFs considered, except HDL-C, increased with age (Figures 1 to 4). This increase 
was observed in all age groups for systolic BP and in both sexes for blood glucose, and only in women 
for TC. Other factors such as BMI, diastolic BP, and TC in men increased up to 65 years and then leveled 
off or decreased slightly.   
Blood sugar levels were greater in men than in women for all age groups and geographic areas, and 
the highest levels of HDL-C were observed in women. Women had lower levels than men for all risk 
factors up to 45 years of age, except for the aforementioned HDL-C levels. Above this age, the mean 
values of CVRFs were similar to those of men, and even exceeded them at ages over 65 years for BMI 
and TC.  
By geographic area, the south-east region had the highest levels of systolic BP, HDL-C, BMI (only in 
those aged over 45 years) ( P <.001), and significantly lower values of TC ( P <.001), whereas blood 









Figure 2. Distribution of the mean systolic blood pressures (SBP) and diastolic blood pressures (DBP) by sex, age, and geographic 





Figure 3. Distribution of the mean of total cholesterol and high-density lipoprotein cholesterol (HDL-C) concentrations by sex, age, 




Figure 4. Distribution of mean blood glucose levels by sex, age, and geographic area. A: men. B: women 
Prevalence of CVRFs by Age, Sex, and Geographic Area 
Table 3 shows the unadjusted prevalences of the different CVRFs in each age and sex group. The 
prevalences of hypertension and DM increased progressively with age in both sexes. This was not the 
case for hypercholesterolemia and obesity, in which stabilization or even a slight decrease after 65 years 
occurred. In contrast, smoking was most prevalent among younger participants and tended to decrease 
significantly with age, above all in women. In the 20-44-year-old age group, all CVRFs were more 
prevalent in men than in women. In the 45-64-year-old age group, except for smoking and DM, which 
were more prevalent among men, women tended to be more obese (35.1% vs 24.8%) and had similar 
levels of hypercholesterolemia and hypertension to men. For those older than 65 years, in contrast, the 
prevalence of risk factors, except for smoking, was greater in women than in men.   
  
Table 3. Unadjusted Prevalences by Age and Sex of the Different Cardiovascular Risk Factors 
 Age Group, y  Sex 
 < 45  45-64  ≥ 65   
 % 95% CI  % 95% CI  % 95% CI  % 95% CI 
 
Smoking (n=19 654) 
Men  53.7  51.7-55.7   38.6  36.8-40.5   21.3  19.9-22.7   35.9  34.9-36.9 
Women  40.4  38.5-42.3   6.5  5.7-7.4   2.5  2.1-3   13  12.4-13.7 
Obesity (n=19 729) 
Men  15.9  14.4-17.4   26.5  24.8-28.2   22.5  21.1-23.9   21.9  21-22.8 
Women  13.3  12.1-14.7   36.7  35.1-38.4   34.8  33.4-36.1   30.1  29.3-31 
Diabetes (n=16 240) 
Men  2.3  1.7-3   9.6  8.5-10.8   12.9  11.8-14.1   8.9  8.3-9.5 
Women  1.1  0.8-1.6   8.1  7.2-9.1   13.3  12.4-14.3   8.7  8.2-9.3 
Hypercholesterolemia (TC >250 mg/dL) (n=15 713) 
Men  14.1  12.7-15.5   24.3  22.7-25.9   18.7  17.4-20   19.2  18.3-20  
Women  6.1  5.2-7   24.6  23.2-26.1   26  24.8-27.3   20.7  19.9-21.5 
Hypercholesterolemia (TC >200 mg/dL) (n=15 713) 
Men  45.1  43.1-47.1   59.8  57.9-61.6   43.7  42-45.3   49.2  48.1-50.2 
Women  32.9  31.1-34.7   59.6  57.9-61.3   48.1  46.7-49.5   48  47-48.9  
Hypertension (n=19 729) 
Men  22.5  20.8-24.2   49  47-50.8   66.4  64.9-68   48.5  47.5-49.6 
Women  10.3  9.2-11.5   50.3  48.6-52   74.1  72.8-75.3   51  50.1-52 
            
 
TC indicates total cholesterol. 
Table 4 shows the adjusted prevalences of the different CVRFs. The most common CVRFs in the 
Spanish population were, in descending order: hypercholesterolemia (46.7%) taken as TC >200 mg/dL, 
hypertension (37.6%), smoking (32.2%), obesity (22.8%), and finally DM (6.2%). If we use the cutoff for 
TC of 250 mg/dL, the prevalence of hypercholesterolemia drops to fourth place (17.1%).   
By geographic area, the highest adjusted prevalences (Table 4) were observed for smoking (34.2%), 
hypertension (42%), and obesity (26.5%) in the south- east regions; obesity was also very frequent in the 
northern regions (26.8%). Diabetes mellitus (7.8%) and hypercholesterolemia (54.8% with TC >200 
mg/dL and 20% with TC >250 mg/dL) were more frequent in the Mediterranean area.   
The prevalence ratios between geographic areas with greatest and least burden for each CVRF were 
significant in all cases ( P <.0001). By order of size, these prevalence ratios were 1.76 for 
hypercholesterolemia, 1.53 for DM, 1.34 for obesity, 1.33 for smoking, and 1.19 for hypertension.  
  
Table 4. Adjusted Prevalences of the Different Cardiovascular Risk Factors in the Total Population and by Large Geographic Areas 











       
Smoking (n=19 654)  25.7 (21-30.4) 28.8 (27-30.6) 33.6 (31.6-35.6) 34.2 (32.4-36) 32.2 (31.1-33.2) 1.33 (1.21-1.46) 
Obesity (n=19 729)  26.8 (23-30.5) 19.9 (18.7-21.2) 24.2 (22.9-25.6) 26.5 (25-28) 22.8 (22.1-23.5) 1.34 (1.22-1.48) 
Diabetes (n=16 240)  5.1 (3.8-6.5) 7.8 (7.1-8.5) 6 (5.4-6.6) 6.3 (5.5-7) 6.2 (5.9-6.6) 1.53 (1.25-1.86) 
Hypercholesterolemia 
(TC >250 mg/dL) 
(n=15 713) 
17.8 (14.8-20.8) 20 (18.7-21.3) 17.1 (16-18.2) 12.7 (11.7-13.8) 17.1 (16.4-17.7) 1.57 (1.42-1.74) 
Hypercholesterolemia 
(TC >200 mg/dL) 
(n=15 713) 
49.7 (44.2-55.2) 54.8 (52.5-57.1) 49.9 (47.9-52) 31.2 (29.6-32.9) 46.7 (45.7-47.8) 1.76 (1.64-1.87) 
Hypertension (n=19 
729)  
37.8 (34-41.5) 35.2 (33.6-36.7) 36.6 (34.8-37.8) 42 (40-44) 37.6 (36.7-38.4) 1.19 (1.11-1.27) 
       
 
TC indicates total cholesterol; CI, confidence interval. 
a Adjusted by the direct method using the Spanish population in 2006 as the standard population. 
b Prevalence ratio calculated using the lowest value for each factor as the reference value 
Discussion   
The basic questions raised by this study are how valid is pooling individual data from participants in 
different studies for a single evaluation of CVRFs and to what extent can the findings of the different 
studies be considered as applicable to Spain as a whole?   
The homogeneity of the results among studies suggests that it is legitimate to pool their individual 
data, and this pooling clearly increases the statistical power and precision of the estimators, in turn 
contributing to better internal validity of the studies. This represents an advantage with respect to 
estimates made by metaanalyses, in which the unit of analysis is each study instead of each individual. In 
addition to pooling of individual data, this can provide knowledge of the mean values of each of the 
CVRFs for each age group, sex, and geographic area considered.   
This study provides an estimate of the prevalence according to age, sex, and large geographic areas, of 
the main CVRFs in the Spanish population, with an objective measure of these factors in almost 20 000 
subjects. The findings of our study reveal a high prevalence of modifiable CVRFs in the Spanish 
population, and specifically indicate that 38% of the Spanish population suffers from hypertension, 32% 
smokes (37% of men and 13% of women), 23% is obese, and 17% has TC levels greater than 250 mg/dL 
and 47% has levels greater than 200 mg/dL, and 6% suffers from diabetes. These figures are similar to 
those of other neighboring countries,23,24 and seem to be in line with other previous analyses of the 
Spanish population.8 Some of these results are worthy of comment.   
Our study confirms a high prevalence of hypertension in the Spanish population, and this prevalence 
is even higher than that found in the metaanalysis by Medrano et al.8 This increased prevalence of 
hypertension becomes accentuated in older individuals, being as high as 74% in women and 66% in men, 
and is very similar to that found in other studies in elderly populations.25,26 The distribution of systolic BP 
and diastolic BP according to age also agrees with the observations of other studies. Whereas diastolic BP 
increases up to middle age and then starts to decrease, systolic BP continues to increase linearly with 
age.27 The increase in systolic BP with age is more marked in women, particularly those aged over 65 
years, thereby explaining the greater prevalence of isolated systolic BP in these women compared to 
elderly men.   
The prevalence of hypercholesterolemia (with a cutoff for TC >250 mg/dL19 ) is very similar to that 
found in other Spanish studies.8 In a country like Spain, with a relatively low incidence of ischemic heart 
disease, and where TC seems to have a lower attributable fraction, it may make more sense to consider 
hypercholesterolemia according to several cutoffs, as too strict a definition  (200 mg/dL) might not reflect 
the real situation in a population such as the Spanish one. In fact, when we use a cutoff of 200 mg/dL, the 
prevalence almost triples. In addition, the mean levels of TC in the middle-aged adult population in all the 
areas considered, except the South- East, exceed this value. As the population ages, the mean 
concentrations of TC increase, particularly in women. Age also seems to invert the differences observed 
between sexes, both with regard to mean values of TC as the prevalence of hypercholesterolemia. With 
regard to the geographic distribution, the south-east area is noteworthy for the lower frequency of 
hypercholesterolemia, lower levels of TC, and higher levels of HLD-C, all of which may be linked to 
nutritional factors.28  
Smoking is clearly more frequent in men than in women, follows a north-south gradient, and declines 
with age, thereby confirming findings reported in other studies.29,30 The prevalence obtained in this study 
is similar to that of the metaanalysis of Medrano et al8 (33%) and also agrees with that of the Spanish 
National Health Survey31 of 1997.  
Also of note is the high prevalence of obesity, above all in women. This prevalence is greater than that 
reported in other studies such as the one by Medrano et al.8 The prevalence of obesity increases with age32 
and stabilizes after 65 years, although the differences between sexes are accentuated from this time on, a 
finding also observed in other studies performed in Spain.33  
The prevalence of obesity is higher in the South-East than in the North, where indices of excess 
weight are also higher in the younger population. Over the years, several studies have observed a 
tendency towards higher BMI and higher rates of obesity in Spain,34 although these rates are still below 
those reported for the American population.35 If this increasing tendency towards obesity is confirmed, 
this will imply an increase in the attributed mortality, which in Spain is estimated to be around 28 000 
deaths per year.36 The prevalence of DM in Spain is estimated to be 6.2% for those aged between 30 and 
65 years, and 10% for those aged between 30 and 89 years.37 In our study, the prevalence in the group 
aged 20 to 64 years (6%) coincides with that estimated by Goday between the ages of 30 and 64 years, 
and it is also very similar (9%) if the population over 65 years is included. Differences are also observed 
in the prevalence of diabetes by geographic area, and of note is the highest rate in the Mediterranean area, 
which also shows mean blood glucose values greater than those of other areas analyzed. The high 
percentage of high blood glucose levels in fasting conditions observed in the male population over 45 
years in the Mediterranean might be, in itself, an indicator of prediabetic states and of increased 
cardiovascular risk.38  
With regard to the second question considered, this study was not designed to estimate the national 
prevalence of each of the different CVRFs investigated. To answer such a question, a study of national 
scope would have to be designed with standardized methods. In our analysis, we only aimed to analyze 
whether the geographic differences in the prevalence and distribution of the CVRFs could explain the 
geographic differences observed in the incidence and mortality of cardiovascular disease among 
regions.39 In Spain, a north-south and west-east pattern of cardiovascular mortality has been described40 
and, according to the most recent data from the Municipal Mortality Atlas of the Carlos III Health 
Institute,41 Extremadura, Andalusia, and Levante are geographic areas where the risk of death from 
ischemic heart disease is greater. The IBERICA study, carried out in different Spanish provinces, also 
showed that there was a certain north-south gradient in the incidence and lethality of ischemic heart 
disease.42 To explain these regional differences with our results, we might highlight the higher prevalence 
of smoking, higher levels of systolic BP, and high rates of obesity and excess weight in the south-east 
area, which would confirm that observed in other studies that describe a similar pattern for the south-east 
area. To explain this pattern, it is also necessary to take into account the high prevalence of diabetes and 
hypercholesterolemia reported in the Mediterranean area. Nevertheless, it is necessary to consider that the 
different CVRFs may interact synergistically, such that the cardiovascular risk derived from simultaneous 
exposure to several factors at once is greater than might be derived from the simple sum of the 
corresponding risks of each factor.   
The present study has certain limitations that should be taken into account. This study pooled data 
from different studies and so has certain limitations associated with such an analysis, particularly in terms 
of quality of data, which depends on each of the individual studies included. Specifically, the results 
should be analyzed with care for the variables and subgroups of age and sex indicated in which significant 
heterogeneity am ong the studies was observed. Likewise, the estimate of the prevalence of certain 
disorders, such as hypercholesterolemia in those aged over 65 years, depends essentially on a single study 
(EPICARDIAN), which measured cholesterol levels in the older population. Similarly, although the 
criteria for classification used were the same, the measures were done by different investigators, devices, 
and laboratories, and so certain variability could have been introduced into the estimates that cannot be 
quantified. However, this study provides a measure of the population frequency taking into account the 
geographic area. In this sense, we should remember the limitation that not all geographic areas are equally 
represented in the study and that the distribution by age reflects an older population. This could affect to a 
certain extent the estimate, but not the trends described or the differences observed. Thus, the main 
contribution of this study is that, until present, data on the frequency and distribution of CVRFs in the 
Spanish population were not known with sufficient precision, either because broad samples of the 
population were not available, such as the studies of clinical examinations, or because an objective 
measure of the risk factors was missing such as is the case with the official health surveys. Finally, the 
data from the metaanalysis based on pooling estimators summarized for each study, without pooling or 
analysis of the individual data of the participants, are subject to substantial heterogeneity and show large 
discrepancies in the diagnostic criteria used. In contrast, this study provides a unified diagnostic criterion 
for each of the factors analyzed and includes data from almost 20 000 individuals recruited in different 
population-based studies performed in Spain between 1992 and 2001. Compared to the metaanalysis of 
Medrano et al,8 it is therefore less heterogeneous because of the methodological similarities of the studies 
included and a precise estimate (narrower CI) of the prevalence of the CVRFs, as the analysis is based on 
pooling individual data and not on summarized data from the studies. In addition, the data were analyzed 
more exhaustively, with calculation of the mean values, and an assessment of how these changed with 
age, sex, and geographic area. The metaanalysis of Medrano et al, on the other hand, focussed only on 
estimating the prevalence of CVRFs by sex for the overall Spanish population, and did not consider data 
by age groups.   
In short, we can conclude that in Spain the prevalence of the main CVRFs is probably high and 
similar to that observed in neighboring European countries. The prevalence of obesity, hypertension, 
hypercholesterolemia, and DM tends to increase with age, and the increase is more evident in women. 
Smoking, in contrast, is more prevalent at younger ages and tends to decrease significantly after 45 years 
of age. The geographic differences observed in the extent and distribution of these risk factors might help 
explain the differences in the pattern of incidence and mortality due to ischemic heart disease reported in 
Spain.   
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